Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

14.59 -0.20 (-1.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 611,151
Open 14.63
Bid (Size) 12.70 (200)
Ask (Size) 13.80 (1,600)
Prev. Close 14.79
Today's Range 14.42 - 14.79
52wk Range 4.190 - 17.58
Shares Outstanding 107,808,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Silence Therapeutics to Participate in Three September Investor Conferences
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
From Silence Therapeutics plc
Via Business Wire

Performance

YTD
+137.2%
+137.2%
1 Month
+29.8%
+29.8%
3 Month
+136.5%
+136.5%
6 Month
+134.2%
+134.2%
1 Year
+179.0%
+179.0%

More News

Read More
News headline image
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial ↗
Via MarketBeat
News headline image
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
From Silence Therapeutics plc
Via Business Wire
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
From Silence Therapeutics plc
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
From Silence Therapeutics plc
Via Business Wire
News headline image
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
From Silence Therapeutics plc
Via Business Wire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
Monday's session: gap up and gap down stocks ↗
Via Chartmill
Here are the top movers in Monday's session. ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
Which stocks are gapping on Friday? ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
Via Chartmill
Here are the top movers in Thursday's session. ↗
Via Chartmill

Frequently Asked Questions

Is Silence Therapeutics Plc - American Depository Share publicly traded?
Yes, Silence Therapeutics Plc - American Depository Share is publicly traded.
What exchange does Silence Therapeutics Plc - American Depository Share trade on?
Silence Therapeutics Plc - American Depository Share trades on the Nasdaq Stock Market
What is the ticker symbol for Silence Therapeutics Plc - American Depository Share?
The ticker symbol for Silence Therapeutics Plc - American Depository Share is SLN on the Nasdaq Stock Market
What is the current price of Silence Therapeutics Plc - American Depository Share?
The current price of Silence Therapeutics Plc - American Depository Share is 14.59
When was Silence Therapeutics Plc - American Depository Share last traded?
The last trade of Silence Therapeutics Plc - American Depository Share was at 09/04/26 04:00 PM ET
What is the market capitalization of Silence Therapeutics Plc - American Depository Share?
The market capitalization of Silence Therapeutics Plc - American Depository Share is 1.57B
How many shares of Silence Therapeutics Plc - American Depository Share are outstanding?
Silence Therapeutics Plc - American Depository Share has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.